March 2019

Gina Nguyen

Nguyen
QBI Director- Marketing/Events

I evangelize the work at the Quantitative Biosciences Institute through communications, experiential marketing, and events including advertising campaigns, flash-talks, seminars, and symposia. As a content creator myself, I also supervise the development of media releases such as podcasts, videos, photos, graphics and branding collateral for print, and the QBI website and social media.

My aim is to make science more accessible—bridging the gap between academia and the general public by applying the methods and approaches I’ve refined in my years of experience in marketing and promotion.

Jacqueline Fabius

Fabius
ACAD PRG MGR 1 (6083)

I manage the operations, collaborations, and team building for the Quantitative Biosciences Institute. I support the Director and the vision of QBI by building domestic and international collaborations that translate into symposia, seminars, and funding opportunities. I oversee the administration, finances, communications, and media for QBI. I also create and implement special programs at QBI such as the scholarships for women from developing nations or regions of interest.

Demanding change: 2019 Distinguished Alumnus Glen L. Stimmel, PharmD

“Challenging the status quo leads to very good things,” said Glen L. Stimmel, PharmD ’72, who has spent a career doing just that. As a motto, it has served him, and his profession, quite well.

Stimmel, the 2019 UCSF Pharmacy Alumni Association Distinguished Alumnus of the Year, has taken his own course through life, and in the process, he helped create the subspecialty of psychiatric pharmacy and expanded the scope of practice for California pharmacists.

2019 Koda-Kimble Seed Award supports School of Pharmacy’s boldest ideas

The 2019 Mary Anne Koda-Kimble Seed Award for Innovation will fund nine bold research projects, ranging from studies of the molecular underpinnings of cancer to focus groups designed to prepare PharmD students for experiential learning.

School of Pharmacy scientists unearth a new target for treating Parkinson’s disease

Scientists in the UCSF School of Pharmacy recently identified the first drug-binding target site on a molecule known to play a role in Parkinson's disease, opening the door to a new generation of therapies for the condition.